Combination of pembrolizumab plus temozolomide therapy in unresectable and advanced melanoma: a multicenter retrospective analysis in China

BACKGROUND: This study aimed to evaluate the effect of anti-PD-1 combined with temozolomide as front-line therapy in patients with unresectable advanced melanoma. METHODS: The records of patients with unresectable advanced melanoma first treated with pembrolizumab plus temozolomide, pembrolizumab al...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Tu, Sun, Wei, Xu, Yu, Qu, Xinglong, Jin, Yongjia, Luo, Zhiguo, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640901/
https://www.ncbi.nlm.nih.gov/pubmed/34926669
http://dx.doi.org/10.21037/atm-21-5738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640901/
https://www.ncbi.nlm.nih.gov/pubmed/34926669
http://dx.doi.org/10.21037/atm-21-5738

Ejemplares similares